BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

First AI to Refine Medical Coding by Exploring Therapeutic Data

DxPrime provides physicians and clinical documentation improvement (CDI) teams with information about missing and wrongly coded diagnoses and procedur...

June 02, 2022 | News

Biosynth Carbosynth Expands Life Sciences Platform with Acquisition of Aalto Bio Reagents

The acquisition represents a further milestone in Biosynth’s development, which broadens its capabilities and offering to the IVD industry. Aalto&rsq...

May 30, 2022 | News

ROVENSA becomes global leader in BioSolutions through the integration of COSMOCEL

COSMOCEL is a leader in specialty biostimulants with a high value-added portfolio and a consolidated commercial footprint in North America,&...

May 27, 2022 | News

Excelra Partners with HotSpot Therapeutics to Enhance Allosteric Drug Discovery Efforts

HotSpot Therapeutics plans to deploy data from Excelra's flagship product GOSTAR toward select protein targets to augment its allosteric inhibitor candidat...

May 26, 2022 | News

CJ BIO and NatureWorks Working Towards a Master Collaboration Agreement to Commercialize Novel Biopolymer Solutions

CJ BIO, a division of South Korea-based CJ CheilJedang and leading producer of polyhydroxyalkanoate (PHA), and NatureWorks, an advanced materials comp...

May 25, 2022 | News

Biotage Launches New High Volume Automated Sample Preparation Workstation

Like its predecessors the Biotage® Extrahera™ HV-5000 maintains the family’s small footprint, intuitive software, and precision engineering...

May 18, 2022 | News

ExoCoBio Receives Japanese Patent for Alleviating Dermatitis with Adipose Stem Cell-Derived Exosome

ExoCoBio Inc., one of global top 4 for stem cell exosome industry, announced that it received from Japanese Patent Office the patent which claims tha...

May 09, 2022 | News

SCG Cell Therapy announces HSA clinical trial approval of TCR-T cell therapy for liver cancer

SCG101 is the first TCR-T cell therapy product to receive a multi-regional Investigational New Drug (IND) approval from Singapore's Health Scie...

May 09, 2022 | News

Matica Bio Opens New Cell and Gene Therapy GMP Facility in Texas

Cell and Gene Therapy Specialty Building on years of cell and gene therapy expertise, Matica Bio’s new facility is now expanding its capacity as a C...

May 04, 2022 | News

Biocytogen Enters into Antibody Agreement with Merck

Under the agreement, Biocytogen will provide Merck antibodies directed against at least three targets specified by them from Biocytogen's Project Integrum&...

May 02, 2022 | News

WuXi Biologics' 2021 ESG Report Reveals Company's Strong Commitment to Overall Sustainability

One example of WuXi Biologics' contribution to society is its rapid, robust pandemic response -- enabling nearly 30 Investigational New Drug Applications (...

April 28, 2022 | News

PharmAbcine Announces Positive Results for Its Novel TIE2-Activating Antibody in GLP Toxicology Study

PMC-403 can stabilize and repair damaged and pathologically leaky blood vessels, and it is being developed to treat AMD (Age-related Macular Degeneration),...

April 27, 2022 | News

Seegene unveils world's first commercialized '3 Ct' PCR assay

"Dream MDx technology" developed based on Seegene's 20-year expertise; combines 19 different patented technologies, including DPO™, TOCE™, Mu...

April 27, 2022 | News

Biocon Biologics’ Insugen® Awarded a Three-Year Contract by Ministry of Health, Malaysia

Biocon Sdn. Bhd. a subsidiary of Biocon Biologics in Malaysia, will manufacture and supply its range of insulins to its partner Duopharma Marketing Sdn. Bh...

April 26, 2022 | News

Stay Connected